10 Amgen regulatory affairs leaders
Associate Vice President, Executive Director, Regulatory Affairs CMC and Director, Regulatory Affairs - Therapeutic Strategy Gen Med Cardiovascular are among the current titles held by these Amgen regulatory affairs leaders. A reader can learn how regulatory affairs leaders work at Amgen from people who have held the role.
Professionals to explore
Adam J. Rupert, MS, RAC
LinkedInExperience: Executive Director Regulatory Affairs · Amgen
Adam J. Rupert has been Executive Director Regulatory Affairs at Amgen since June 2021, based in Ventura County, California. At Amgen, Adam J. Rupert was Director Regulatory Affairs from 2018 to 2021, Senior Manager Regulatory Affairs from 2015 to 2018 and Regulatory Affairs Manager from 2012 to 2015, and was Regulatory Affairs Specialist at International Partnership for Microbicides from 2010 to 2012.
David Shechter
LinkedInExperience: Regulatory Affairs Director · Amgen
David Shechter has been Regulatory Affairs Director at Amgen since October 2024, based in Thousand Oaks, California. At Amgen, David Shechter was Senior Manager Regulatory Affairs from 2015 to 2024 and Senior Manager, Medical Communications from 2006 to 2015, and was Associate Director, Data Development and Analytic Computing (DDAC) at Thomson Reuters from 2003 to 2006.
Jennifer Steinbock
LinkedInExperience: Senior Director Regulatory Affairs · Amgen
Jennifer Steinbock has been Senior Director Regulatory Affairs at Amgen since March 2024, based in the Los Angeles Metropolitan Area. At Amgen, Jennifer Steinbock was Director Global Regulatory Affairs from 2019 to 2024, Senior Manager Regulatory Affairs from 2016 to 2019, Regulatory Affairs Manager from 2012 to 2016 and United States Regulatory Professional from 2011 to 2012.
Joanna Chu
LinkedInExperience: Director of Regulatory Affairs · Amgen
Joanna Chu has been Director of Regulatory Affairs at Amgen since May 2025, based in the San Francisco Bay Area, and the profile headline reads Director of Regulatory Affairs | Bioscience Regulatory Affairs. Joanna Chu was Director of Regulatory Affairs at Gilead Sciences from 2021 to 2025 and Associate Director at Genentech from 2017 to 2021.
Leanna Gentry, PhD, RAC
LinkedInExperience: Regulatory Affairs Director · Amgen
Leanna Gentry has been Regulatory Affairs Director at Amgen since April 2024. At Chiesi USA, Inc., Leanna Gentry was Global Regulatory Affairs Manager from 2023 to 2024, Manager, US Regulatory Affairs R&D - Pipeline from 2020 to 2023 and Senior Associate, US Regulatory Affairs R&D - Pipeline from 2019 to 2020.
Michael J. Abernathy
LinkedInExperience: Associate Vice President · Amgen
Michael J. Abernathy has been Associate Vice President at Amgen since April 2025, and the profile headline reads Associate Vice President, Global Regulatory Affairs at Amgen Regulatory Digital Innovation Lead. The listing also shows Michael J. Abernathy as Executive Director at Amgen since 2016 and Director, Regulatory Affairs at Amgen since 2012.
Natalie M. Perico-Norred
LinkedInExperience: Director Regulatory Affairs Chemistry, Manufacturing and Controls (CMC) · Amgen
Natalie M. Perico-Norred has been Director Regulatory Affairs Chemistry, Manufacturing and Controls (CMC) at Amgen since February 2021, based in Thousand Oaks, California. At Amgen, Natalie M. Perico-Norred was Senior Manager Regulatory Affairs Chemistry, Manufacturing and Controls (CMC) from 2016 to 2021 and Manager Regulatory Affairs Chemistry, Manufacturing and Controls (CMC) from 2010 to 2016.
Suhasini Kanagala
LinkedInExperience: Director, Global Regulatory Affairs · Amgen
Suhasini Kanagala has been Director, Global Regulatory Affairs at Amgen since October 2022, based in the San Francisco Bay Area. At ChemoCentryx, Suhasini Kanagala was Director, Global Regulatory Affairs from 2021 to 2022, Associate Director, Global Regulatory Affairs from 2019 to 2021 and Senior Manager, Regulatory Affairs from 2017 to 2019.
Tabetha M. Bonacci
LinkedInExperience: Executive Director, Regulatory Affairs CMC · Amgen
Tabetha M. Bonacci has been Executive Director, Regulatory Affairs CMC at Amgen since May 2025, based in the Greater Minneapolis-St. Paul Area. At Amgen, Tabetha M. Bonacci was Director, Regulatory Affairs - CMC from 2018 to 2025, Senior Manager, Regulatory Affairs - CMC from 2015 to 2018 and Manager, Regulatory Affairs- CMC from 2011 to 2015, and was IOTF Fellow at FDA from 2009 to 2011.
Tanya Chaudhri, PharmD, MSc
LinkedInExperience: Director, Regulatory Affairs - Therapeutic Strategy Gen Med Cardiovascular · Amgen
Tanya Chaudhri has been Director, Regulatory Affairs - Therapeutic Strategy Gen Med Cardiovascular at Amgen since March 2025, based in Wheeling, Illinois. Tanya Chaudhri was Associate Director, Regulatory Affairs - Therapeutic Strategy Ophthalmology at Amgen from 2023 to 2025 and Senior Manager, Regulatory Affairs - Therapeutic Strategy Ophthalmology at Horizon from 2022 to 2023.
Choose the right perspective
Match the scope in a person's title, such as global regulatory affairs, therapeutic strategy or regulatory CMC, to the question you need answered. Weigh how recently each person held the role and whether a director-level or executive-level view fits your question better.
Questions to take into the conversation
- 01What did you focus on first when you took on your regulatory affairs role at Amgen?
- 02What has changed in how you approach regulatory work since you took on your current role?
- 03What has your own work at Amgen taught you about building a regulatory affairs team?
Reaching Amgen regulatory affairs leaders
How can I contact one of these Amgen regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Amgen, based on profile data retrieved on October 24, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Amgen regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Amgen regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal